Combiwave SF

Combiwave SF

salmeterol + fluticasone

Manufacturer:

Glenmark

Distributor:

Glenmark
Concise Prescribing Info
Contents
Per Combiwave SF 50 MDI Salmeterol xinafoate 25 mcg, fluticasone propionate 50 mcg. Per Combiwave SF 125 MDI Salmeterol xinafoate 25 mcg, fluticasone propionate 125 mcg. Per Combiwave SF 250 MDI Salmeterol xinafoate 25 mcg, fluticasone propionate 250 mcg
Indications/Uses
Treatment of asthma where combination therapy of bronchodilator & inhaled costicosteroid is appropriate: In patients not adequately controlled w/ inhaled corticosteroids & 'as needed' inhaled short-acting β-2 agonist; patients already adequately controlled on both inhaled corticosteroid & long-acting β-2 agonist.
Dosage/Direction for Use
Adult & adolescent >12 yr 2 inhalations bid. Childn ≥4 yr 2 inhalations of 25 mcg/50 mcg bid. Max of 100 mcg bid.
Special Precautions
Should not be used as treatment for acute asthma symptoms. May worsen conditions if use during exacerbation of asthma attack. Treatment should not be stopped abruptly. Patients w/ pulmonary TB, severe CV disorders, heart rhythm abnormalities, DM, thyrotoxicosis, uncorrected hypokalemia or patients predisposed to low levels of serum K. Discontinue use, assess patient & institute alternative therapy if increase in wheezing after dosing occur. Possible systemic effects may occur during long-term therapy. Avoid concomitant use w/ ritonavir, ketoconazole or other potent CYP3A4 inhibitors. May develop pneumonia in patients w/ severe COPD. Black African or Afro-Caribbean patients. Pregnancy & lactation.
Adverse Reactions
Headache; nasopharyngitis. Candidiasis of the mouth & throat, pneumonia, bronchitis; hypokalemia; hoarseness/dysphonia, sinusitis; contusions; traumatic fractures, arthralgia, myalgia.
Drug Interactions
Avoid use w/ non-selective & selective β-blockers; β-adrenergic-containing drugs. Fluticasone: Increased plasma conc w/ ritonavir. Increased systemic exposure w/ ketoconazole & itraconazole. Salmeterol: Increased risk of systemic side effects w/ ketoconazole.
ATC Classification
R03AK06 - salmeterol and fluticasone ; Belongs to the class of adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics. Used in the treatment of obstructive airway diseases.
Presentation/Packing
Form
Combiwave SF 50 MDI 25 mcg/50 mcg
Packing/Price
14 mL x 1's (P290/box)
Form
Combiwave SF 250 MDI 25 mcg/250 mcg
Packing/Price
14 mL x 1's (P620/box)
Form
Combiwave SF 125 MDI 25 mcg/125 mcg
Packing/Price
14 mL x 1's (P435/box)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in